Publication: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Loading...
Program
relationships.isAuthorOf
Author
TÜRK, HACI MEHMET
Tsuboi M.
Herbst R. S.
John T.
Kato T.
Majem M.
Grohé C.
Wang J.
Goldman J. W.
Lu S.
Advisor
Date
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Description
Source
Keywords
Keywords
Citation
Tsuboi M., Herbst R. S., John T., Kato T., Majem M., Grohé C., Wang J., Goldman J. W., Lu S., Su W., et al., "Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.", The New England journal of medicine, cilt.389, sa.2, ss.137-147, 2023